Scientists have discovered that a low dose of the discontinued antibiotic cephaloridine can induce beneficial metabolites in gut bacteria, extending lifespan in both nematodes and mice. This research reveals a novel pathway for microbiota-based therapeutics that bypass traditional antibiotic mechanisms to promote host health.